B

Braidwell Portfolio holdings

AUM $3.13B
1-Year Est. Return 31.52%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+31.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.13B
AUM Growth
-$243M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
93
New
Increased
Reduced
Closed

Top Buys

1 +$55.4M
2 +$42.4M
3 +$40.1M
4
CLDX icon
Celldex Therapeutics
CLDX
+$33.4M
5
ILMN icon
Illumina
ILMN
+$31.7M

Top Sells

1 +$74.8M
2 +$67M
3 +$58.5M
4
APGE icon
Apogee Therapeutics
APGE
+$54.4M
5
DHR icon
Danaher
DHR
+$42M

Sector Composition

1 Healthcare 83.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RARE icon
76
Ultragenyx Pharmaceutical
RARE
$2.22B
-588,700
REPL icon
77
Replimune Group
REPL
$591M
-2,750,092
RNAM
78
Avidity Biosciences
RNAM
$11.2B
-331,907
RPRX icon
79
Royalty Pharma
RPRX
$20.3B
-182,068
SRPT icon
80
Sarepta Therapeutics
SRPT
$1.71B
-832,100
THC icon
81
Tenet Healthcare
THC
$20.4B
-121,700
VKTX icon
82
Viking Therapeutics
VKTX
$3.85B
-759,455
SION
83
Sionna Therapeutics
SION
$1.51B
-314,013
HTFL
84
Heartflow Inc
HTFL
$2.05B
-50,000